Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of EYPT will decline by -64.57% over the next 2 Weeks and hit $1.62 by Tuesday, September 15, 2026. In that time frame, EYPT's share price is expected to range between $0.00 and $4.39.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 15, 2026 | 0.00 | 1.62 | 4.39 |
| Sep 14, 2026 | 0.00 | 1.63 | 4.44 |
| Sep 11, 2026 | 0.32 | 3.19 | 5.94 |
| Sep 10, 2026 | 0.01 | 2.98 | 5.78 |
| Sep 9, 2026 | 0.23 | 3.10 | 5.95 |
| Sep 8, 2026 | 0.58 | 3.08 | 5.75 |
| Sep 7, 2026 | 0.00 | 3.08 | 5.70 |
| Sep 4, 2026 | 1.84 | 4.65 | 7.67 |
| Sep 3, 2026 | 1.75 | 4.44 | 7.05 |
| Sep 2, 2026 | 1.67 | 4.56 | 7.37 |
EYPT shares rose +4.59% in Wednesday, September 2, 2026's trading session, rising from a previous close of $4.58 to move at $4.79. The stock demonstrated notable intraday movement (see EYPT's key stats for a full breakdown), fluctuating between $4.33 and $4.80, a +10.98% trading range. While recent weeks have seen some volatility, EYPT has managed to secure a -23.97% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 3.26M shares changing hands, 245.7K fewer than the previous session. This amounted to $15.62M in total market activity.
Will EYPT Continue Its Downward Trend?
According to analyst ratings and projections for EYPT, EyePoint Pharmaceuticals, Inc. shares are anticipated to decrease by -9.08%, potentially reaching $4.39 per share by September 15, 2026. Short-term technical indicators for EYPT currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 17 negative trading days within the past 30 sessions. Based on the EYPT stock forecast, now is not the best time to buy EYPT stock because its current trading price is +195.15% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on EYPT covering social and institutional perspectives.
EYPT Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into EYPT's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 29.39% to 32.23%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 37.87%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 42.38%, maintains a neutral outlook for the long term. Insights into EYPT's shareholder base show how institutional investors are positioning themselves during these momentum shifts
EyePoint Pharmaceuticals Short-Term Forecasts
EYPT Forecast For Next 5 Days
Our algorithm anticipates EyePoint Pharmaceuticals (EYPT) stock could hit $2.09 by Sep 09, 2026. This represents a -56.27% fall from today's price, following a -2.51% change over the past five days.
EYPT Forecast For Next 30 Days
Based on analysis of market trends, the outlook for EyePoint Pharmaceuticals, Inc. (EYPT) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $1.36, which would mean a -71.61% decrease from the current price of $4.79. Projections for this period range from a high of $5.27 to a low of $0.00.
EYPT Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for EyePoint Pharmaceuticals's price over the next three months point to a rise. EYPT stock is expected to peak at $10.61 on Sep 16, 2026 before potentially dipping to $5.31 on Oct 09, 2026. On average, EYPT is likely to trade around $8.11 in the coming 90 days.
EyePoint Pharmaceuticals Stock Forecast 2025
Based on our predictive models, EyePoint Pharmaceuticals (EYPT) is expected to trade between $5.31 and $12.64 throughout 2026. This would result in an average price of $8.83, potentially offering investors a +84.34% return from current levels.
EyePoint Pharmaceuticals, Inc. Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, EyePoint Pharmaceuticals, Inc. (EYPT) is positioned to show a strong performance in September 2026. The price is predicted to move between $7.24 and $10.61, settling at an average of $8.98. This could translate to a +87.47% gain.
October 2026
Based on current market signals, EyePoint Pharmaceuticals, Inc. is projected to trend october 2026. We forecast a trading range from $5.31 to $9.74, with a likely average price of $7.71. Investors could expect a potential return of +60.96%.
November 2026
Our predictive algorithms indicate EyePoint Pharmaceuticals, Inc. stock may see a shift in November 2026. The expected range spans $5.87–$9.26, with an average target of $7.56. This represents a positive outlook and a possible gain of +57.83%.
December 2026
Analyzing established trends, EyePoint Pharmaceuticals, Inc. looks set to move in December 2026. Projections place the stock between $7.46 and $12.64, averaging around $10.91. This suggests a +127.77% gain from current levels.
January 2027
Market indicators suggest EyePoint Pharmaceuticals, Inc. could experience notable changes during January 2027. Prices could fluctuate within $3.44 to $9.76, with a midpoint forecast of $6.41. The stock might deliver a +33.82% gain.
February 2027
Forecasting for February 2027, models estimate that EyePoint Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $3.72 and $8.54, averaging $7.57. This signals a positive trajectory with potential returns around +58.04%.
March 2027
According to our latest forecast models, EyePoint Pharmaceuticals, Inc. (EYPT) is positioned to show a strong performance in March 2027. The price is predicted to move between $1.61 and $8.74, settling at an average of $7.34. This could translate to a +53.24% gain.
April 2027
Based on current market signals, EyePoint Pharmaceuticals, Inc. is projected to trend april 2027. We forecast a trading range from $0.00 to $10.07, with a likely average price of $8.65. Investors could expect a potential return of +80.58%.
May 2027
Our predictive algorithms indicate EyePoint Pharmaceuticals, Inc. stock may see a shift in May 2027. The expected range spans $0.00–$8.48, with an average target of $7.20. This represents a positive outlook and a possible gain of +50.31%.
June 2027
Analyzing established trends, EyePoint Pharmaceuticals, Inc. looks set to move in June 2027. Projections place the stock between $0.00 and $7.11, averaging around $4.89. This suggests a +2.09% gain from current levels.
July 2027
Market indicators suggest EyePoint Pharmaceuticals, Inc. could experience notable changes during July 2027. Prices could fluctuate within $0.00 to $8.24, with a midpoint forecast of $6.04. The stock might deliver a +26.10% gain.
August 2027
Forecasting for August 2027, models estimate that EyePoint Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $7.98, averaging $5.01. This signals a positive trajectory with potential returns around +4.59%.
September 2027
According to our latest forecast models, EyePoint Pharmaceuticals, Inc. (EYPT) is positioned to show a strong performance in September 2027. The price is predicted to move between $0.00 and $6.69, settling at an average of $4.50. This could translate to a -6.05% loss.
EYPT's history of dividends and stock splits also plays a role in long-term investor confidence.